Sam North

Content and SEO lead

Sam combines more than a decade of hands-on cannabis cultivation experience with six years working across content, SEO, and digital strategy.

After moving from cultivation into cannabis writing in 2020, his role developed beyond editorial content to encompass SEO, content strategy, and search-led digital growth. His experience now spans editorial and educational content, search-led website strategy, and the use of performance data to guide how content is structured, developed, and improved. Central to his work is a passion for cannabis education, helping to destigmatise cannabis through clear, accurate, and accessible information.

Since 2023, Sam has focused predominantly on the UK medical cannabis sector. At Glass Pharms®, he leads content and SEO, helping shape the company’s website and organic search strategy while communicating the science, technology and expertise behind its approach to pharmaceutical cannabis cultivation.

Articles by

Opinion on UK Medical Cannabis Growth

Opinion Piece on UK Medical Cannabis The growth of UK medical cannabis has been significant, albeit slower than other comparable countries such as Germany or Australia. This opinion piece, published in the Business of Cannabis, explores the UK market growth. Read More
Continue Reading about Opinion on UK Medical Cannabis Growth

CIC Masterclass

James Duckenfield delivering masterclass on UK medical cannabis regulations and microbial loads Our CEO, James Duckenfield, presented on UK regulations and in particular how UK standards are significantly higher than competitors in other countries. The Cannabis Industry Council event took place at law firm Irwin Mitchell.
Continue Reading about CIC Masterclass

100th Shipment Milestone

100th Weekly Shipment Glass Pharms operates a continuous cultivation facility, allowing us to ship fresh product to customers every week. Last week, we reached a milestone with our 100th weekly shipment.
Continue Reading about 100th Shipment Milestone

Exploring risk in the medical cannabis supply chain

Supply Chain Risk Report Glass Pharms contributed to this insightful view of supply chain risk in medical cannabis as it matures to a substantial industry. This Relm Risk Briefing: Cannabis 2026 shares learnings from that experience. It investigates how regulation, insurance, and operational practice intersect across the global supply chain, drawing on data and conversations with market leaders who are setting new standards in safety, sustainability, and accountability. Read More
Continue Reading about Exploring risk in the medical cannabis supply chain

Coverage on S4C

Featured on S4C Glass Pharms featured on @S4C Supporting the conversation on the future of pharmaceutical cannabis in the UK.   Watch now from 06:56–09:57 
Continue Reading about Coverage on S4C

Featured on BBC iPlayer

Featured as part of a documentary on cannabis in the UK Glass Pharms featured on @BBCiPlayer Supporting the conversation on the future of pharmaceutical cannabis in the UK.   Watch now from 06:56–09:57 
Continue Reading about Featured on BBC iPlayer